Insights on Off-Patent and Generic Medicines - Generics Bulletin
Jul 4, 2017 · Stay updated with the latest news and insights on the generics market. Explore Citeline’s Generics Bulletin for industry trends and analysis.
Generics Bulletin: unrivaled news and analysis of the global …
A trusted industry source since 2003, Citeline’s Generics Bulletin delivers in-depth news and analysis on the latest regulatory, legal, market, and commercial developments in the global generics, biosimilars, and value-added medicines industries.
Products - Generics Bulletin
Oct 17, 2024 · The latest twist in MSN’s legal fight with Novartis over Entresto has seen a US court rule that the FDA was correct to approve MSN’s skinny-label generic, which carves out certain protected Entresto indications. However, an appeal has already been filed and an imminent generic launch looks unlikely.
Regulation - Generics Bulletin
Oct 1, 2024 · Generics Bulletin recaps the most recent regulatory news from across the world. Regulation Generic Drugs. 17 Sep 2024. Opinion. US Interchangeability ‘Irrelevant’ And ‘Makes No Sense’ Says Sandoz. By David Wallace.
Pharma Intelligence | Generics Bulletin: Your continuous online …
Generics Bulletin: Your continuous online source for Generics, Biosimilars and Value-Added Medicines insight. Access to unparalleled news, expert coverage and analysis anytime, anywhere.
Pharma Intelligence | Generics bulletin - Informa
Generics bulletin delivers all the information you need to make better decisions faster. Join thousands of subscribers from companies in nearly 60 countries who are already benefitting from commercial intelligence about business opportunities in the global generic medicines and biosimilars markets.
The Generics Bulletin Top 50
Find out in the 2022 edition of Generics Bulletin’s annual Top 50 ranking of companies in the off-patent sector. Internal Changes Reflected in Top 10 Shifts. Download your free article pack now to explore this year’s Top 10 rankings – including shake-ups for …
Generics bulletin on Twitter: "Amgen Achieves A First With …
Feb 24, 2023 · Amgen Achieves A First With European Eculizumab Nod. Amgen has received a positive opinion from the EMA’s CHMP recommending that its Bekemv eculizumab biosimilar …
Help :: Generics Bulletin
Offers unrivalled coverage, news and analysis of the global generics, biosimilars and value-added medicines industries.
Generics/News - GaBi Online
Generics/News | Posted 21/10/2022. On 7 September 2022, Dr Reddy’s Laboratories (Dr Reddy’s) announced the US launch of their generic lenalidomide capsules. And in July 2022, Lupin announced that its generic azilsartan medoxomil tablets had been approved by the US Food and Drug Administration (FDA).